peck.press

№ 974,356

https://www.facebook.com/share/p/1Gxiwt6CYx/

FuckTheGovernment · 2026-10-29 · 33 min read · treechat · tx f7243d…2039 · block 973,134

https://www.facebook.com/share/p/1Gxiwt6CYx/

Why wont you talk about this???

WHAT USA , CANADA, UK , AUSTRALIA ARE DOING TODAY PUSHING "DIGITAL ID BIOMETRICS" & DRONE SURVEILLANCE IS NOTHING NEW TO ISRAEL!

WE ARE JUST 10 YEARS BEHIND THEM AND NOW FOLLOWING THEIR BLUEPRINT! THEY WERE THE TESTING GROUNDS FOR WHATS COMMING TO THE WEST TODAY IN REAL-TIME!

2013 was the year Israel began issuing digital biometric identity cards.  The Biometric Database Law was passed in 2009 to authorize the collection of biometric data, with a voluntary pilot program launching that year. By June 2017, the transition to mandatory biometric smart IDs was completed, making them the only type of ID card issued for new applications. https://search.brave.com/search?q=what+year+was+digital+id+deoyed+in+Israel%3F&source=android&conversation=09bacbe9c3ad8672ce84851f3035e098c084 . Israel has used drones to surveil Palestinians in the occupied West Bank and Gaza Strip since the mid-2010s, with reports indicating that small surveillance drones were flown in areas like Masafer Yatta to monitor and intimidate Palestinian communities.

While the Israeli military began using drones for surveillance and reconnaissance in the 1970s (initially using US-made Firebees and later developing indigenous models like the IAI Scout), these were primarily deployed against state actors or for tactical military intelligence during conflicts. The specific expansion of drone surveillance over Palestinian civilian populations in the West Bank escalated in the late 2010's https://search.brave.com/search?q=what+year+did+Israel+start+using+drones+to+surveil+their+citizens%3F&source=android&conversation=09ba57d7e9429da2a8707669332d595eac00 . USA IS CURRENTLY BUILDING THE SAME SURVEILLANCE "KILL CHAINS/LISTS" SYSTEMS IN 2026! THIS IS THEIR PROGRAM: Project Flytrap: Accelerating Offensive Maneuver through Data-Centric Kill Web | AUSA 2026 https://www.youtube.com/watch?v=PGRg8h0hUQo . This is what is being built here in the west in real-time TODAY!

Lavender is an AI system developed by Israel’s Unit 8200 intelligence division that assigns every person in Gaza a risk score from 1 to 100 to indicate the likelihood of affiliation with Hamas or Palestinian Islamic Jihad.

The algorithm processes massive datasets, including cellphone metadata, WhatsApp network connections, address changes, and social media presence, to generate these probabilistic scores. Individuals with high scores were added to a "kill list" that reportedly identified up to 37,000 Palestinians as suspected militants. The system operated with an acknowledged 10% error rate, meaning approximately one in ten individuals flagged were not actually militants. Human officers reportedly reviewed these AI-generated scores with minimal oversight, often spending only about 20 seconds per target before authorizing strikes. https://search.brave.com/search?q=project+lavender+kill+scores&source=android&conversation=09a8371d77eca4c5a744a22968fd33d0a832 . . https://www.facebook.com/share/p/1eCJfLKL3V/

JUST SEARCH SOME BILL GATES & EPSTEIN "GLOBAL HEALTH TYPE BUISNE$$"!!!

Just search these Keywords Below 👀!

"Global Health"

"Crypto health"

"Preparing for pandemics"

"DARPA"

"Boris Nikolic"

"GATES"

7. "Life sciences"

JUST CLICK HERE: https://www.justice.gov/epstein

VERIFY YOU ARE 19+ AND SCROLL HALFWAY DOWN THE PAGE LOOK FOR THE SEARCH BAR AND START TYPING SIMPLE KEYWORD SEARCHES & LEARNING HOW THE WORLD ACTUALLY WORKS & NOT THE BULLSHIT THEY KEEP SHOWING YOU ON YOUR NEWS MEDIA AND FED SLOP SOCIAL MEDIA FEEDS! . EFTA00973929

From: Boris Nikolic •t: Ina> To: "Jeffrey Epstein (jeevacation@gmail.com)" jeevacation@gmail.com Subject: draft for a fund Date: Tue, 22 Oct 2013 00:13:56 +0000

"This is a draft that I sent to Yuri on Friday. Please let's discuss. Life Sciences & Technology ("LST") Fund With a target size of [$250 - $400 million] of committed capital, the LST Fund intends to invest at the intersection of life science and digital technology. Recent advances in molecular medicine, electronic sensor technology and communication platforms create the opportunity to dramatically reduce inefficiencies in the diagnosis, treatment and delivery of healthcare. Similar to other industries, the life sciences and healthcare sectors could be transformed by disruptive business models that change the way consumers — otherwise known as patients — interact with health care. In an environment of health care reform requiring quality, affordable care, the LST Fund will invest in companies with transformative technologies and business models that create financial value either through making healthcare more efficient and/or serving consumers directly. The LST Fund's portfolio is expected to comprise approximately [20-25] companies with an average of [$10-15 million] invested per company. The investment period of the LST Fund will be [4-5] years with a 10 year fund life. The General Partners are Yuri Milner and Boris Nikolic. The General Partners intend to invest a significant portion [10-20%) of the capital of the LST Fund. The management fee is 2% and a carried interest is 20% of net gain. Preferred Limited partners will be selected strategic individuals. The LST Fund will be based in San Francisco, and co-locate with DST Global in order to take advantage of the back office capabilities of DST. The LST Fund intends to be an investor in disruptive business models and will therefore be disciplined about investing only in the highest quality entrepreneurs with an unfair advantage in a significant market opportunities. The LST Fund has three areas of focus:

  1. Molecular Medicine. The LST Fund will invest in opportunities in which progress in molecular medicine, genomic and bio-informatics makes possible the identification, development and delivery of more effective and efficient treatments. Medicine is evolving toward a regime of personalized medicine through a positive feedback loop between the consumer, treatment, and new treatment development. For example, sequencing cancer cells can identify drug-able targets to tailor oncology therapies to the needs of patients. Drug development can be more efficient through analyzing data from large numbers of individuals, or individuals with unique responses to illness, allows for more efficient identification of target compounds. In addition to cancer and chronic diseases, we will invest in companies that are developing new products in sectors that consumers are willing to pay for such as skincare, hair loss and weight loss.
  2. Smart Sensors and Big Data. The LST Fund will invest in opportunities in which progress in electronics, computing analytics and communications make possible new approaches of direct-to-consumer monitoring, EFTA00973929 diagnosing and delivering healthcare. Low cost sensor technologies allow for cheap monitoring of body systems such as heart rate, excretion, activity and caloric consumption. Data from sensors, as well as broader social networks, can be aggregated and mined for behavior patterns and market research. In turn, smart algorithms can allow for integrated, consumer-controlled diagnosis and treatment recommendations within alternative lower-cost delivery settings. Finally, smart sensors and big data can lead to new methods for promoting patient adherence to treatment regimes, improving efficacy and reducing long-term health care costs.
  3. Digital Health Platforms. The LST Fund will invest in opportunities in which technology-enabled, consumer-facing business models will disrupt the healthcare ecosystem. Consumers will use their mobile phones and social networks to understand and make choices about health care providers, companies and products. Innovative companies will use digital health platforms to break down the barriers to delivery of efficient health services. Quality, affordability and accessibility of healthcare will be enhanced through feedback loops between customers using services and companies adapting to the needs of consumers. The General Partners, Yuri Milner and Boris Nikolic, expect that the vast majority of investment opportunities will be sourced through the networks of their partners. This investment team melds the unique skills and networks of two Principals: Boris Nikolic's deep expertise and networks in molecular medicine, diagnostics and technology innovation, and Yuri Milner's track record in investing in some of the world's most transformative technology companies. As Chief Advisor for Science and Technology to Bill Gates, Dr. Nikolic has been involved in the investment activities of the Bill and Melinda Gates Foundation, Intellectual Ventures, Microsoft and Mr. Gates' direct investment portfolio, and therefore has relationships with some of the best scientists, inventors, innovators, entrepreneurs and VCs in the world. As CEO of DST Global, Yuri Milner has invested in companies such as Facebook, Zynga, Twitter, Groupon, Airbnb and Uber, and has also formed a unique relationship to source transactions from Y Combinator. Table 1. Committed and Prospective Limited Partners: I already talked to — please note that I discussed a possibility of a fund without mentioning Yuri Milner (except Bill Gates): I. Bill Gates
  4. Jorge Paulo Lemann
  5. David Rubenstein
  6. Kimbal (and Elon) Musk
  7. David Schwartz Within next month, I intend I talk to:
  8. Jonathan and George Soros
  9. David Bonderman
  10. Michael and Pete Peterson
  11. Leonard Lauder
  12. Solina Chao and Li Ka-shing
  13. Eli Jacobs
  14. Denise and Kyle Washington EFTA00973930 13. James Ueltschi" https://www.justice.gov/epstein/files/DataSet%209/EFTA00973929.pdf

  . EFTA01106142

August 8,2013 William H. Gates Re: Request for Jeffrey Epstein to engage in negotiations and discussions on behalf of Dr. Boris Nikolic regarding termination of relationships

"Dear Bill:

You, William H. Gates ("Mr. Gates"), have specifically requested that the undersigned, Jeffrey Epstein ("Mr. Epstein"), personally serve as the representative of Dr. Boris Nikolic ("Dr. Nikolic") in discussions and negotiations with Mr. Gates and his representatives and agents, regarding all financial, logistical and other matters (the "Requested Matters") in connection with the termination of all of Dr. Nikolic's employment, business, financial and other relationships with Mr. Gates, and with Melinda F. Gates, bgC3, LLC, Watermark Estate Management Services, LLC, the Bill and Melinda Gates Foundation and any and all other affiliates of Mr. Gates or any of the foregoing (Melinda F. Gates, bgC3, LLC, Watermark Estate Management Services, LLC, the Bill and Melinda Gates Foundation and such other affiliates collectively hereinafter referred to as "Affiliates"). By signing this Agreement, Mr. Gates confirms that Mr. Epstein has advised Mr. Gates that Mr. Epstein is only willing to serve as Dr. Nikolic's representative in such discussions and negotiations in connection with the Requested Matters on the condition that Mr. Epstein receives full exculpation and indemnification by Mr. Gates from and against any and all claims and liabilities in any way, directly or indirectly, arising out of, relating to, or connected with, the Requested Matters, including without limitation, anything leading up to the date of this Agreement and anything that may hereafter occur. Acknowledging this condition and in order to induce Mr. Epstein to so serve as Dr. Nikolic's representative in connection with the Requested Matters, Mr. Gates hereby agrees with Mr. Epstein as follows:

  1. EXISTING RELATIONSHIPS AND DISCLOSURE OF CONFIDENTIAL AND PROPRIETARY INFORMATION. Mr. Gates acknowledges that Mr. Epstein has an existing collegial relationship with Mr. Gates in which Mr. Epstein received confidential and/or proprietary information from Mr. Gates. In addition, Mr. Gates acknowledges that Mr. Epstein also has an existing collegial relationship with Dr. Nikolic in which Dr. Nikolic has sought Mr. Epstein's counsel regarding matters relating to certain aspects of Dr. Nikolic's employment, business, financial and other relationships with Mr. Gates and the Affiliates, and that in connection therewith, either at the direction of Mr. Gates or with Mr. Gates's full knowledge and 1 EFTA01106142 consent, Dr. Nikolic has disclosed certain confidential and proprietary information of Mr. Gates and the Affiliates to Mr. Epstein. Mr. Gates hereby acknowledges and agrees that the prior disclosure to Mr. Epstein by Dr. Nikolic of any and all confidential and proprietary information of Mr. Gates and/or any of the Affiliates did not violate any legal or contractual obligation of Dr. Nikolic. Mr. Gates also hereby consents and agrees that Dr. Nikolic may hereafter disclose to Mr. Epstein any and all confidential or proprietary information concerning Mr. Gates and the Affiliates that Dr. Nikolic or Mr. Epstein may deem necessary to enable Mr. Epstein to fully and properly serve as Dr. Nikolic's representative in connection with the Requested Matters, provided that Mr. Epstein hereby agrees to use the same only for such purposes and to maintain the confidentiality of such information." https://www.justice.gov/epstein/files/DataSet%209/EFTA01106142.pdf . EFTA00394894

Subject: Re: JE Date: Tue, 26 Feb 2013 18:36:26 +0000

"actually, I think JE meant that Gates would fly with JE on JE's plane...but I could be wrong!"

On Feb 26, 2013, at 1:32 PM, wrote:

"Thank you s0000 much for info, yes interesting on gates to palm bch with gates plane!! C000l! Pick me pick me!! Lol"

Original Message

From: To: To: To: Lynn Fontanilla To: Jojo Fontanilla To: Richard Barnnet To: Lawrence Visoski Subject: JE Sent: Feb 26, 2013 10:25 AM

"JE now tells me that he will go see Bill Gates from 2-3:30 on Wed. Feb. 27th at Four Seasons (same place he met up with Gates last time) Then he will see Bill Gates again at 10:15pm...not sure if this will be at the house or some place else... JE also says he might see Gates again on Thurs. Feb. 28th at 2:00 and then possibly on Friday fly to PB with Gates as his passenger... (which makes me wonder what happened to the lunch at 1pm on Friday march 1 with Gates and Woody Allen!) Obviously, this is all up in the air...I think JE would like to be around for whenever Gates may have free...we will see as things unfold! https://www.justice.gov/epstein/files/DataSet%209/EFTA00394894.pdf . . EFTA01952099

William H. Gates

"Dear Bill: RE: Letter of Agreement Regarding Investment in the Life Science Fund This letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), regarding our respective rights and obligations in connection with the investment by Gates of $10 Million to $20 Million in the Life Science Fund (the "Fund"). With respect to Gates's investment in the Fund, Gates and Dr. Nikolic have agreed as follows: Fund Investment Gates directly or through an affiliate of Gates shall purchase a $10 Million to $20 Million interest in the Fund (the "Fund Investment") Advance The amount that Gate or his affiliate pays to purchase the Fund Investment shall be deemed to be an advance of funds due from Gates to Dr. Nikolic under the prior agreement between Gates and Dr. Nikolic relating to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a certain investment entity and that entity's underlying investments in Foundation Medicine, Inc. and ResearchGate GmbH. As an advance, Dr. Nikolic shall be deemed to bear all downside risk in the Fund Investment, in that Dr. Nikolic shall only be entitled to be paid as provided in this Agreement, even if the Fund Investment should become worthless. Fund Investment At any time and from time to time commencing on the date that Gates or Payment Demands his affiliate purchases the Fund Investment and continuing through and including the third anniversary of said date of purchase (the "Payment Period"), Dr. Nikolic shall have the right, exercisable by written notice to Gates, to demand payment from Gates of the Adjusted Value (as hereinafter defined") of up to all or a portion of the Fund Investment (a "Fund Investment Payment Demand"). Dr. Nikolic may deliver to Gates up to an aggregate of four (4) Fund Investment Payment Demands during the Payment Period. In connection with each Fund Investment Payment Demand, the "Adjusted Value" that Gates shall be required to pay to Dr. Nikolic shall be equal to: I. The portion of the Fund Investment, expressed as a percentage, as to which Dr. Nikolic in his sole discretion elects to make such Fund Investment Payment Demand, multiplied by 2. The difference of (a) the fair market value of the Fund Investment (including all dividends, payments, distributions, securities and other items of value at any time distributed or paid by the Fund in respect of the Fund Investment) as of the date of such Fund Investment SE251912 vl 3. Payment Demand, less (b) 50% of the amount, if any by which said fair market value exceeds the amount originally paid by Gates or his affiliate to purchase the Fund Investment. The portion of the Fund Investment as to which any Fund Investment Payment Demand may be made at any given time may not exceed the difference of 100% less the aggregate percentage of the Fund Investment as to which all then prior Fund Investment Payment Demands were paid by Gates to Dr. Nikolic. Fair Market Values For purposes of calculating the fair market value of the Fund Investment, and the Adjusted Value in connection with each Fund Investment Payment Demand hereunder, the following shall apply: I. Fair market values shall be determined jointly by Gates and Dr. Nikolic, reasonably, in good faith and in accordance with the provisions hereof. 2. No discounts (including, without limitation, minority discounts or discounts for lack of marketability) will be applied in determining fair market values. 3. Whether or not Gates or his affiliate shall hereafter sell, transfer, convey, encumber or otherwise dispose of all or any portion of the Fund Investment, the fair market value of the Fund Investment and the Adjusted Value shall be calculated as if no such sale, transfer, conveyance, encumbrance or other disposition ever occurred. 4. Investment values, net asset values or similar valuations (other than those identified as estimated values) provided by the Fund to its investors in the ordinary course of the Fund's operation shall be presumed to be accurate absent manifest error, bias, gross negligence or willful misconduct on the part of the Fund. 5. Securities traded on any domestic or foreign exchange or included in the NASDAQ Stock Market are valued at their last sale prices reported on the day as of which the value is being determined, or if a security did not trade on such day, the last sale price on the next preceding day on which a sale price was reported. Values in any currency other than U.S. Dollars shall be converted to U.S. Dollars at prevailing exchange rates mutually agreed to by the parties in good faith. 6. In valuing privately held, illiquid securities of a fund or an issuer, the

  1. value of the fund's or issuer's securities will be determined using any valuations of the fund or the issuer relied upon by purchasers in the issuer's or fund's most recent investment round to have occurred prior to the date that Dr. Nikolic makes a given Fund Investment Payment Demand; provided, however, that if any such valuation is more than twelve (12) months old at the time that Dr. Nikolic makes a Fund Investment Payment Demand, then the parties agree to engage a mutually agreed upon independent third party appraiser to provide them with a then current appraisal of the illiquid security sought to be valued.
  2. During the period that Dr. Nikolic is permitted to make Fund Investment Payment Demands hereunder, upon request from Dr. Nikolic, Gates shall give Dr. Nikolic written notice of any dividends, payments, distributions, securities or other items of value distributed or paid by the Fund in connection with the Fund Investment. Such notice shall include all relevant terms, provisions and other details regarding any such dividends, payments, distributions, securities and other items of value so distributed or paid.
  3. At all times while Dr. Nikolic is permitted to make Fund Investment Payment Demands hereunder, upon request from Dr. Nikolic, Gates shall provide Dr. Nikolic with true and correct copies of all valuations, financial statements (whether audited or unaudited), reports and other communications which Gates or Gates's affiliates receives from or delivers to the Fund promptly after receiving or delivering the same, provided Gates is not otherwise legally or contractually prohibited from sharing any such information with a third party. Payment of Adjusted Value in Connection with Fund Investment Payment Demands No Sale of Fund Investment Required Gates shall pay Dr. Nikolic the Adjsuted Value of in connection with each Fund Investment Payment Demand within fifteen (15) days after Gates receives such Fund Investment Payment Demand. Payment shall be made by wire transfer to a proper account designated in writing by Dr. Nikolic to Gates. Default interest shall accrue and be due and payable by Gates to Dr. Nikolic on all such late, outstanding amounts at the default rate of twenty five percent (25%) per annum until all such outstanding amounts are paid in full. Nothing provided in this Agreement shall be deemed to require Gates or any affiliate of Gates to make any sale or other disposition of all or any portion of the Fund Investment in connection with any or all of the Fund Investment Payment Demands by Dr. Nikolic; it being understood that Dr. Nikolic will hold no interest whatsoever in the Fund Investment and that Gates shall be free in his sole discretion to hold for as long as he shall so desire, or to sell, encumber or otherwise dispose of at any time and from time to time, all or
  1. Amendment. This Agreement may not be amended, modified or supplemented other than in writing signed by both parties hereto.
  2. Waiver. Any waiver of any provision hereof must be in writing and shall be effective only in the specific instance and for the specific purpose for which such waiver is given. No failure on the part of either party hereto to exercise, and no delay in exercising, any right, power or privilege under this Agreement shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege under this Agreement preclude any other or fitrther exercise thereof or the exercise of any other right, power or privilege hereunder.
  3. Binding Effect; Assignability. This Agreement shall be binding upon, and inure to the benefit of, the parties hereto and their respective heirs, devisees, successors, and permitted assigns. This Agreement (including the rights and obligations hereunder) shall not be assignable by either party hereto except with the prior written consent of the other party hereto; provided, however, that Dr. Nikolic may assign his rights to receive payments under this Agreement to a wholly owned affiliate of Dr. Nikolic without the prior written consent of Gates, provided further than such wholly owned affiliate may not further assign any such payments without Gates' written consent.
  4. Severability. If any of the covenants, terms, conditions or provisions of this Agreement are held invalid for any reason, such invalidity shall not affect the other covenants, terms, conditions and provisions hereof which can be given effect without the invalid covenant, term, condition or provision, as the covenants, terms conditions and provisions of this Agreement are intended to be and shall be deemed severable.
  5. Counterparts; Delivery. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may be executed and delivered by delivery of a facsimile
  1. Construction. This Agreement shall be deemed to have been prepared, and negotiations shall be deemed to have occurred in connection with such preparation, pursuant to the joint efforts of all of the parties to this Agreement. This Agreement therefore shall be construed simply and fairly and not for or against any party to this Agreement.
  2. Confidentiality. Each party hereto shall treat the terms of this Agreement as confidential and, without the prior written consent of the other party hereto, shall not disclose the terms hereof to any third party; provided, however, that a party hereto may make such disclosure (i) to his accountants, attorneys, tax advisors and other advisors who require the same for the purpose of performing their services for such party; (ii) as required by any law, rule or regulation, or rule of a court or government authority or agency; (iii) in connection with any pleadings, motions, discovery or other filings in any legal proceedings or arbitration arising out of this Agreement; or (iv) in response to a duly authorized subpoena, court order, order from any government authority or other duly authorized discovery or information request. At least five business days (if feasible) prior to making any disclosure pursuant to clause (iv) above (other than in connection with legal proceedings or arbitration arising out of this Agreement pursuant to clause (iii) above), to the extent permissible by applicable laws, rules and regulations, and by rule or order of the applicable court or government authority, the party being asked to make the disclosure shall inform the other party hereto of the disclosure request, so as to permit the other party hereto to seek a protective order or other appropriate relief if he so desires, and the party being asked to make the disclosure will reasonably cooperate with any such effort by the other party hereto; provided, however that nothing provided herein shall prohibit the party being asked to make the disclosure from timely complying with any such subpoena, court order, order from government authority or other duly authorized discovery or information request. " AGREED TO AND ACCEPTED Boris Nikolic AGREED TO AND ACCEPTED William H. Gates https://www.justice.gov/epstein/files/DataSet%2010/EFTA01952097.pdf . . EFTA01747368

Sent Sunday, February 1, 2015 8:36:34 PM Subject take a look at this ra h... From: Michael Wol To: Jeffrey Epstein ieevaca ion gmai .com>

"Here's what I have on this point now re Gates Foundation. Add whatever you can to it, and I'll try again. It's an important enough point, on reconsideration, that it doesn't have to be that simple. "It is Bill Gates who at the end of the summer began prodding Epstein to begin a process of public rehabilitation. Epstein has been advising Gates on a new way to increase the clout of the Gates Foundation by adding a constallation of other chartiable fluids that would be bundled with the Gates operation." https://www.justice.gov/epstein/files/DataSet%2010/EFTA01747368.pdf . EFTA01749938

From: Lesley Groff Subject: Mon. Sept. 8 Sent Friday, September 5, 2014 5:38:02 PM To: Jeffrey Epstein CC cjeevacation@gmail.com>

"Mon. Sept 8. 2014 NY 10:00am Meet Bill Gates and Tom Pritzker at the Park Hyatt Park Hyatt, 153 W. 57" Street JOJO TO DRIVE YOU 11:30am Walk over to Leon Black's office w/Bill Gates, Maybe Tom Pritzker Leon's Office, 9 West 57" Street, 43r4Floor, 12:00pm Larry Summers to join the meeting at Leon's w/Bill Gates (Is this happening??) 2:00pm Mort Zuckerman to meet you at 71" w/Bill Gates (or Four Seasons?) 3-3:30pm Meet Kathy Ruemmier at the Four Seasons w/Bill Gates Four Seasons, 57 East 57" Street 4:00pm Appt w/Ramsey" https://www.justice.gov/epstein/files/DataSet%2010/EFTA01749938.pdf . EFTA00967687

From: Jeffrey Epstein jeevacation@gmail.com To: Terje Rod-Larsen Subject: Fwd: September 11th Meeting Agenda Date: Thu, 22 Aug 2013 12:32:07 +0000  HoA_POLIO_OUTBREAK_Brocure.pdf; IPI_BMGF_9_11_13_Agenda.pdf; ATT00002.htm Forwarded message From: Andrea Pfanzelter 4 Date: Thu, Aug 22, 2013 at 8:24 AM Subject: Fwd: September Ilth Meeting Agenda To: Jeff Epstein Jeevacation@gmail.com, Boris Nikolic < FYI Andrea Begin forwarded message: From: Amy Carter Amv.Carter@gatesfoundation.org Date: August 21, 2013, 23:24:30 GMT+02:00 To: "Andrea Pfanzelter "Walter Kem etnpi@ipirsrg)" <kemp®ipinst.org>, "Nasra Hassan "David Witt (witt@ipinst.org)" <witteipinst.org> Cc: Melissa Covelli West Melissa.Covelli@gatesfoundation.org, Paul Facchini Paul.Facchini@gatesfoundation.org, Mito Alfieri Mito.Alfieri@gatesfoundation.org, "Katie Cleary (Volt)" Katie.Cleary@gatesfoundation.org Subject: September 11th Meeting Agenda

"Dear IPI Team — As promised, attached is an agenda our meeting on Wednesday, September 11th. Thank you again for taking the time to join us in Seattle for this discussion. In addition to the attached agenda, I have a few additional questions and documents to share: I. Confirmation that we will receive your draft proposal by Wednesday, September 4th (via email); 2. Request for the white paper mentioned during our August 7th phone call (paper drafted in advance of your meetings with Mr. Gates and Dr. Nikolic, as I recall); 3. Can you please let me know if you have any dietary restrictions or requests? We will be working through lunch during our meeting on the 11th; 4. Please let me know Mark Shaw's title, location and the best way to connect him (via Video Conference or Phone) to the meeting on the 11th; and, 5. Do you need any additional information on our polio work and strategy? Just in case I have attached, courtesy of Melissa and the Polio Team, a paper on polio in the Horn of Africa. You might also appreciate seeing this link to gain a deeper understanding of our field partners and strategy: http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx Thank you and please let me know if you have any questions about any of the contents of this mail or your trip to Seattle. Sincerely, Amy Amy K. Carter Deputy Director I Family Interest Grants Executive Office" https://www.justice.gov/epstein/files/DataSet%209/EFTA00967686.pdf . EFTA00966770

From: Larry Cohen To: Jeffrey Epstein jeevacation@gmail.com, Bill Gates < Subject: RE: Date: Thu, 01 Aug 2013 15:15:15 +0000 Inline-Images: —WRD000.jpg

"Hi Jeffery — We have from 10:15 — 12:15 held on Thursday August 8th. Our office is at 4000 Carillon Point, Kirkland WA 98033. I thought Boris provided you these details. Let me know if you need any help with transportation to the office. I am not sure what point 3 refers to. Bill is out of the country and I am not sure if/when he will have access to email. The draft agreement states two years as we discussed: Company shall provide Dr. Nikolic a Severance Payment in an amount of equal to the average of his last two year's base salary and bonus, if any, in the total gross amount of Dollars, less applicable deductions and withholding Are you available to talk on the phone today or tomorrow?"

From: Jeffrey Epstein [mailto:jeevacation@gmail.com] Sent: Thursday, August 1, 2013 4:51 AM To: Larry Cohen; Bill Gates Subject: „Image removed by sender.

"I. I am in receipt of the document you sent as well as the email that you proposed that Bill send out. 2. Can you confirm Bill's invitation to me on August 8th. I will need the details. time place etc. 3. Bill has previously sent an email to me authorizing you to talk about employment issues„ I would like a broader authorization as some of the issues at hand you have previously described as outside of Boris's employment. . I would appreciate an email or call from Bill acknowledging his full understanding . some simple preliminary housekeeping items first; I thought there was to be deal points before document drafting but... 1.Shouldn't most covenants be mutual, Melinda and Bill signing .. . 2. The new severance payment in the agreement has been reduced to only one year? is that Bills and Melinda's new position? 3, I assume Bill is aware that Boris would be required to keep some emails to sustain his tax position , ( I will discuss directly with Bill ) 4 the document you sent , makes no mention of the already existing agreement with re Boris's investment override 5. the document changes "at will" to another type of employment, ( why ?). , 6. it makes no mention of Bills commitment to help Boris find another position. 7 If Melinda wants a divorce , how does Boris protect himself. 8 documents that support your authorization to sign on behalf of bg3. , manager binding? if that is the eventual position. I cannot stress enough that Boris is emotionally very fragile.very ! I mentioned this in both of our telephone calls. Can Bill send him an email or something that calms him.?" https://www.justice.gov/epstein/files/DataSet%209/EFTA00966770.pdf . EFTA01961245

To: Boris Nikolic Cc: Jeffrey Epshtein[jeevacationegmail.com] From: ehud barak Sent Fri 8/16/2013 3:15:40 AM Subject Re: Parasight Ltd.

"Hi Boris P1 do . Especially if Parasight is considerably ahead of the wave. Will be glad to meet. I'm in NY on Sep 22-26 for the Clinton GI. Earlier in Sept in Bali and Nigeria. Just let me know what better works for you. Best Ehud Barak "

Sent from my iPad On 12 ma 2013, at 08:28, Boris Nikolic wrote:

"Will do my best. I just had chance to review — there might be a small complexity as we have been funding a company to develop similar system! Nevertheless I will do my best to help any way I can. Hope to see you soon in NYC or Tel Aviv or Davos! Boris"

From: ehud barak Sent: Sunday, August 11, 2013 10:24 PM To: Boris Nikolic Subject: Re: Parasight Ltd.

"Boris Thx. Waiting for your/Gene's response. Best Ehud"

Sent from my iPad On 12 AM 2013, at 07:40, Boris Nikolic

"Thank you Ehud! We will follow up for sure. I am sending this to Gene Walther who is leading diagnostics (including malaria diagnostics) at Bill and Melinda Gates Foundation. I think that Gene is on business travel and vacation right now so it might be some delay. Looking forward to learning more re this promising technology! All the best Boris"

From: ehud barak Sent: Sunday, August 11, 2013 9:51 AM To: Boris Nikolic Subject: Fwd: Parasight Ltd.

"Dear Boris Attached as promised pl find Parasight presentation. P1 send me your initial response and we'll consider how to continue with them. Best Ehud Barak"

Sent from my iPhonc Begin forwarded message: From: Down Date: August 11, 2013, 18:52:33 GMT+03:00 To: Ehud BARAK <ehbarak I (agmail.com> Subject: Fwd: Parasight Ltd.

"Dear Dr. Nikolic, Parasight Ltd was founded two years ago in Israel in order to develop a platform technology for blood analysis and parasite detection. During this time, Parasight has focused on developing an innovative device for the accurate, rapid and inexpensive diagnosis of Malaria, suitable for POC and labs in Malaria-endemic  countries as well as blood banks everywhere. The device is based on the latest technologies in the field of machine-vision together with breakthrough advances in sample preparation and staining. Following Mr. Barak's communication with you, we are proud to present the official report describing the results of our first clinical trial, which was conducted recently in India by the National Institute of Malaria Research. As the report indicates, our clinical accuracy is on par with PCR, but with ease of use and cost commensurate with RDTs. Additionally, I am attaching an executive summary describing the company. Our goal is to introduce Parasight's technology to the Gates Foundation in hopes of advancing the project and reaching the target population. As it happens, our co-founder and Chairman of the Scientific Advisory Board, Dr. Daniel Levner, is a Senior Staff Scientist at Harvard Medical School, so perhaps the best way to present our technology would be through a meeting. Please let me know what would be best for you. Thanks, 'foss' Pollak Chief EXOellthelt Officer Parasight Jerusalem I echnology Park. Israel Yosai Pollak "

<CL-IN002_Report_signed.pdf> https://www.justice.gov/epstein/files/DataSet%2010/EFTA01961245.pdf . EFTA00973929

From: Boris Nikolic •t: Ina> To: "Jeffrey Epstein (jeevacation@gmail.com)" jeevacation@gmail.com Subject: draft for a fund Date: Tue, 22 Oct 2013 00:13:56 +0000

"This is a draft that I sent to Yuri on Friday. Please let's discuss. Life Sciences & Technology ("LST") Fund With a target size of [$250 - $400 million] of committed capital, the LST Fund intends to invest at the intersection of life science and digital technology. Recent advances in molecular medicine, electronic sensor technology and communication platforms create the opportunity to dramatically reduce inefficiencies in the diagnosis, treatment and delivery of healthcare. Similar to other industries, the life sciences and healthcare sectors could be transformed by disruptive business models that change the way consumers — otherwise known as patients — interact with health care. In an environment of health care reform requiring quality, affordable care, the LST Fund will invest in companies with transformative technologies and business models that create financial value either through making healthcare more efficient and/or serving consumers directly. The LST Fund's portfolio is expected to comprise approximately [20-25] companies with an average of [$10-15 million] invested per company. The investment period of the LST Fund will be [4-5] years with a 10 year fund life. The General Partners are Yuri Milner and Boris Nikolic. The General Partners intend to invest a significant portion [10-20%) of the capital of the LST Fund. The management fee is 2% and a carried interest is 20% of net gain. Preferred Limited partners will be selected strategic individuals. The LST Fund will be based in San Francisco, and co-locate with DST Global in order to take advantage of the back office capabilities of DST. The LST Fund intends to be an investor in disruptive business models and will therefore be disciplined about investing only in the highest quality entrepreneurs with an unfair advantage in a significant market opportunities. The LST Fund has three areas of focus:

  1. Molecular Medicine. The LST Fund will invest in opportunities in which progress in molecular medicine, genomic and bio-informatics makes possible the identification, development and delivery of more effective and efficient treatments. Medicine is evolving toward a regime of personalized medicine through a positive feedback loop between the consumer, treatment, and new treatment development. For example, sequencing cancer cells can identify drug-able targets to tailor oncology therapies to the needs of patients. Drug development can be more efficient through analyzing data from large numbers of individuals, or individuals with unique responses to illness, allows for more efficient identification of target compounds. In addition to cancer and chronic diseases, we will invest in companies that are developing new products in sectors that consumers are willing to pay for such as skincare, hair loss and weight loss.
  2. Smart Sensors and Big Data. The LST Fund will invest in opportunities in which progress in electronics, computing analytics and communications make possible new approaches of direct-to-consumer monitoring, EFTA00973929 diagnosing and delivering healthcare. Low cost sensor technologies allow for cheap monitoring of body systems such as heart rate, excretion, activity and caloric consumption. Data from sensors, as well as broader social networks, can be aggregated and mined for behavior patterns and market research. In turn, smart algorithms can allow for integrated, consumer-controlled diagnosis and treatment recommendations w